Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Full-dose S-1 vs reduced-dose S-1 + oxaliplatin in older patients with metastatic colorectal cancer
2014-000394-39Phase 2Completed
- Sponsor
- University Hospital Odense
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of tegafur in metastatic colon cancer (mCRC) (2 arms), sponsored by University Hospital Odense. Primary endpoints: Progression-free survival and Time-to failure of strategy. Started Mar 2014; status: completed.
02
Drugs
tegafur
03
Conditions
metastatic colon cancer (mCRC)
Beyond the preview
Go deeper on 2014-000394-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000394-39.